Adverse overall survival impact of PD-L1 positivity in patients with KRAS G12C mutation is abolished by the immunotherapy
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
7
References
0
Citations
NaN
KQI